Online Pharma Times World News | February 23, 2011 Selina McKee Shares in French drugmaker Transgene took a small knock yesterday in Europe after Swiss drug giant Roche cut its ties with the firm’s vaccine for HPV-caused diseases. Roche terminated its 2007 agreement with Transgene under which it held exclusive global development and commercialisation rights […]
VRM: Gardasil/Cervarix – A Legacy Of Shame
Vaccine Resistant Movement
by Joel Lord
20th February 2011 – By Joel Lord
The headlines alone tell the whole story. ‘Teenage girl left brain-damaged after receiving cervical cancer jab‘, ‘Thousands of UK schoolgirls have suffered adverse reactions…several reported multiple reactions’, ‘20,575 adverse reactions, 352 reports of abnormal pap smears post vaccination, 89 reported deaths’, ‘New Worries About Gardasil Safety’, ‘Cervical Cancer Vaccine May Raise Risk of Guillain-Barre Syndrome’, ‘8 more deaths connected to HPV vaccine’…
FDA Misquotes Merck's Gardasil Claims
Laguna Natural Health eNews and Tips
February 19, 2011
The misinformation regarding Merck’s billion dollar baby, Gardasil, has spiraled out of control. The FDA has claimed the three part intramuscular vaccine “prevents” cancer, yet Merck does not. In a recent article, the FDA also approved Gardasil “for the prevention of anal cancer”, as claimed below:
“PRNewswire-USNewswire/ –The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.
Reasons for “NOT” (or the moratorium) with respect to the vaccine against the virus of papiloma human
Equipo CESCA Spain February 18, 2009 Escrito en Buitrago del Lozoya (Madrid, España), el miércoles 18 de febrero de 2009 por Juan Gérvas Médico de Canencia de la Sierra, Garganta de los Montes y El Cuadrón (Madrid). Profesor (Salud Pública) en la Facultad de Medicina de la Universidad Autónoma de Madrid. Translation 1/ In order […]
Gardasil safe and effective in young men
nam aidsmap Michael Carter Published: 07 February 2011 The Gardasil vaccine prevents infection and disease associated with high-risk strains of human papilloma virus (HPV) in males, an international team of investigators report in the February 3rd edition of The New England Journal of Medicine. Sexually experienced boys and young men aged between 16 and 26 […]
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »
